Skip to content
← Back to this collection

PUBLICATIONS · 34902335

Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2022 Jan
First author
Yau C

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2022 Mar;23(3):e95. doi: 10.1016/S1470-2045(22)00011-0.
    note
    Source null
    related pmid
    35240096
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2022 Mar;23(3):e96. doi: 10.1016/S1470-2045(22)00085-7.
    note
    Source null
    related pmid
    35240097
    relationship
    Comment in

Authors and identifiers

  1. name
    Yau C
    type
    Author
  2. name
    Osdoit M
    type
    Author
  3. name
    van der Noordaa M
    type
    Author
  4. name
    Shad S
    type
    Author
  5. name
    Wei J
    type
    Author
  6. name
    de Croze D
    type
    Author
  7. name
    Hamy AS
    type
    Author
  8. name
    Laé M
    type
    Author
  9. name
    Reyal F
    type
    Author
  10. name
    Sonke GS
    type
    Author
  11. name
    Steenbruggen TG
    type
    Author
  12. name
    van Seijen M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Yau C
    type
    Author
  2. name
    Osdoit M
    type
    Author
  3. name
    van der Noordaa M
    type
    Author
  4. name
    Shad S
    type
    Author
  5. name
    Wei J
    type
    Author
  6. name
    de Croze D
    type
    Author
  7. name
    Hamy AS
    type
    Author
  8. name
    Laé M
    type
    Author
  9. name
    Reyal F
    type
    Author
  10. name
    Sonke GS
    type
    Author
  11. name
    Steenbruggen TG
    type
    Author
  12. name
    van Seijen M
    type
    Author
bibliography ids
  1. nci-bib-a91a55f808767f6d4618eb32
book metadata
content sha256
3a5977c91fcf2c6fca678547c07268ddbc6af21c4dda875036ff9cc31a7202a8
document type
citation
dois
  1. 10.1016/S1470-2045(21)00589-1
electronic publication date
display
2021 Dec 11
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34902335
immutable id
pubmed:34902335@3a5977c91fcf2c6fca678547c07268ddbc6af21c4dda875036ff9cc31a7202a8
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
1
name
The Lancet. Oncology
nlm unique id
100957246
pages
149-160
volume
23
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2022 Mar;23(3):e95. doi: 10.1016/S1470-2045(22)00011-0.
    note
    Source null
    related pmid
    35240096
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2022 Mar;23(3):e96. doi: 10.1016/S1470-2045(22)00085-7.
    note
    Source null
    related pmid
    35240097
    relationship
    Comment in
outcomes validated
false
pmid
34902335
provenance
batch id
3f4d1914d2afe41e9e70
provider
NCBI PubMed ESummary
record sha256
f2cd5e602cf9bdca13ef5377377a6cb8240eefcc25843291ec934bc59f3bd0ec
response sha256
0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
retrieved at
2026-09-09T23:48:06.522634+00:00
publication date
display
2022 Jan
precision
month
year
2022
publication types
  1. Journal Article
  2. Multicenter Study
  3. Research Support, N.I.H., Extramural
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34902335/
title
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.

Preserved source evidence · Not medical advice